Howard D. Sterling has over 50 years of experience leading and advising innovative healthcare and technology companies, participating in over 150 NASDAQ IPOs. As an attorney, investment banker, founder, director, and consultant, he has pioneered taking Israeli companies public in the US. Currently, he is the CEO and inventor of Rama Mail, which aims to prevent phishing using blockchain and biometrics. He also co-founded Alpha Tau Medical to develop an intra-tumoral cancer therapy using radioactive particles and has advised both Aoxing Pharmaceutical and Foamix Pharmaceutical in strategic financing including NASDAQ IPOs.

1. Page 1 of 5
Howard David Sterling
www.slideshare.net/search/slideshow?searchfrom=header&q=howard+sterling
https://www.youtube.com/user/SterlingGroupIntl
Strategic thinker, solver &
implementer; Leader & innovator
in pioneering disruptively
innovative healthcare & high-
technologies in USA, Israel,
China & other countries.
Participated in over 150
NASDAQ IPOs as attorney,
investment banker, founder,
director, and consultant.
Inventor & CEO: Patent Core
concepts of Rama Mail-
completely prevents phishing.
145 West 67 Street, Suite 31D
New York, NY 10023
+1-646-409-5356
+972-52-659-5882
howard.david.sterling@gmail.com

2. Page 2 of 5
www.alphataumedical co-
founder
Pioneer in taking Israeli
healthcare companies to
NASDAQ IPOs since
1981………
Aoxing Pharmaceutical (AXN
NYSE) Director, Chairman of
Audit Committee……………
ATM, uniquely using intra-tumoral
DaRTs devices with Ra224 emitting α
particles, most effective solid tumor
therapy with no/small side effects &
consistent abscopal effect.
Latest FOMX (unique topical derm
drugs), raised $160 million; 1981 laser
Industries (first medical laser)
InterPharm Laboratories (among first
genetic engineering companies).
AXN, China-based, producer of Chinese
herbals and leader in bringing opioid
therapeutics to China partnering with
leading opioid Scottish company

3. Page 3 of 5
EXPERIENCE
Rama Mail, Israel — CEO and
Core Inventor
June 2017 - PRESENT
Dreamt of integration of core
concepts of blockchain and Small
Biometric Signature
Alpha Tau Medical, Israel—
Co-Founder and Director
April 2015-present
Uniquely using Ra224
intratumorally, dissolves all solid
tumors in days with no side
effects. Responsible for strategic
large pharmaceutical partners and
strategic financiers
Foamix Pharmaceutical--Israel-
-Primary consultant on $160
million NASDAQ IPO
May 2014-September 2015
Responsible for obtaining major
underwriters and all aspects of
NASDAQ IPO
Various Investment Banks
2010-2014
Sand Bros. Venture Capital
Funds-New York---COO &
head of Investment Banking
SKILLS
 Strategic major financing
 Disruptive Invention
 Pioneer in NASDAQ IPOs for Israeli
companies since 1981
 Software companies to
NASDAQ IPOs since 1965
 Taken 160 companies to NASDAQ
as attorney, consultant or investment
banker
Education
Cornell Agricultural School. 1958-1960.
First in class
Columbia University, 1960-1962, BS,
Economics, Cum Laude, Phi Beta Kappa
Harvard Law School, 1962-1968, Magna
Cum Laude, Harvard Law Review,
Published Paper on “Broker Dealer
Bankruptcy” Harvard Law Review, leading
to SIPC by Congress
“Broker Dealers should be able to Go
Public” UCLA Law Review. Leading to
allowance by NYSE of Members being
publicly traded.
IMAGINE IT IS 1965: As IPO attorney, I
did IPO prospectus’ for PLI compiler &
simulation software companies, new
concepts at time.

4. Page 4 of 5
April 1996-2010
COO of $175 million venture
funds focused on fiber-optic
switches, cabling and quantum
photonics.
Oscar Gruss & Sons-Israel-
Head of Investment Banking.
1991-1996
Pioneer, first USA investment
banker to have office in Israel.
Did 11 NASDAQ IPOs for Israel
companies.
Various Investment Banks
1983-1991
Rifkind & Sterling,
attorneys. Beverly Hills-Senior
Partner
1965-1983
Headed 55 attorneys completely
focused on NASDAQ IPOs,
primarily high-tech electronics
and med-tech. International
reputation.

5. Page 5 of 5
Co-Founder and Grants
Committee Chairman, Concern
Foundation for Cancer Research,
1968-1983, Beverly Hills, CA
SUMMARY: Howard D. Sterling
has been leading IPO attorney,
director, investment banker
consultant, CEO-inventor, &
founder of innovative medical
device, pharmaceutical & high-
tech companies since 1965
focused on NASDAQ IPOs.
Strategic thinker, strategic solver;
strategic implementer in USA,
Israel and China latest, AXN,
FOMX and alphatau.com
Concern was first charity focused on
immune-oncology, currently most
fashionable new cancer therapy. Concern
endowed, under my pioneering leadership
and research, Lautenberg Center for
General and Tumor Immunology.